Back Foley Viewpoints FDA and the Importance of Confidentiality October 1, 2012 Share on LinkedInShare on TwitterPrintShare by EmailShare Back to top Partner David Rosen authored an article that appeared in the October 2012 issue of BioPharm International titled “FDA and the Importance of Confidentiality.” Click here to read the complete article. Author(s) David L. Rosen [email protected] Washington, D.C. 202.672.5430 Related Insights View All Posts June 13, 2025 Foley Viewpoints Eighth Circuit Affirms Summary Judgment to Insurer in Dispute with Construction Project Owner Over Lost Rental Income On Monday, June 9, 2025, the Eighth Circuit Court of Appeals ruled that a Missouri real estate developer could not recover insurance… June 13, 2025 Foley Viewpoints Your Company Received an ICE Notice of Inspection — Now What? “Worksite enforcement operations are going to massively expand,” according to a June 12, 2025, interview[1] with Border Czar Tom Homan…. June 13, 2025 Energy Current Key Provisions of the One Big Beautiful Bill (H.R.1) Related to Foreign Ownership and Foreign Supply (FEOC) Applicable Limitations on Tax Credits under Sections 48E, 45Y, and 45X: The below summary describes provisions in the One Big Beautiful…
